Koh Miura

Dr. Koh Miura


Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2010 in Cancers
Verified
Journal Article
Open access
PDF file
KMKoh Miura
Koh Miura
MKMakoto Kinouchi
Makoto Kinouchi
KIKazuyuki Ishida
Kazuyuki Ishida
WFWataru Fujibuchi
Wataru Fujibuchi
TNTakeshi Naitoh
Takeshi Naitoh
ISIwao Sasaki
Iwao Sasaki
5-Fluorouracil (5-FU) is a key anticancer drug that for its broad antitumor activity, as well as for its synergism with other anticancer drugs, has been used to treat various types of malignancies. In chemotherapeutic regimens, 5-FU has been combined with oxaliplatin, irinotecan and other drugs as a continuous intravenous infusion. Recent clinical chemotherapy studies have shown that several of the regimens with oral 5-FU drugs are not inferior compared to those involving continuous 5-FU infusion chemotherapy, and it is probable that in some regimens continuous 5-FU infusion can be replaced by oral 5-FU drugs. Historically, both the pharmaceutical industry and academia in Japan have been involved in the development of oral 5-FU drugs, and this review will focus on the current knowledge of 5-FU anabolism and catabolism, and the available information about the various orally-administrable 5-FU drugs, including UFT, S-1 and capecitabine. Clinical studies comparing the efficacy and adverse events of S-1 and capecitabine have been reported, and the accumulated results should be utilized to optimize the treatment of cancer patients. On the other hand, it is essential to elucidate the pharmacokinetic mechanism of each of the newly-developed drugs, to correctly select the drugs for each patient in the clinical setting, and to further develop optimized drug derivatives.

9 January 2008 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
HKH. Kinoshita
H. Kinoshita
HUH. Uchida
H. Uchida
YKY. Kawai
Y. Kawai
TKT. Kawasaki
T. Kawasaki
NWN. Wakahara
N. Wakahara
TST. Saito
T. Saito
Aims: To characterize the adhesion molecule of Lactobacillus plantarum LA 318 that shows high adhesion to human colonic mucin (HCM). Methods and Results: The adhesion test used the BIACORE assay where PBS‐washed bacterial cells showed a significant decrease in adherence to HCM than distilled water‐washed cells. A component in the PBS wash fraction adhered to the HCM and a main protein was detected as a c. 40‐kDa band using SDS‐PAGE. Using homology comparisons of the N‐terminal amino acid sequences compared with sequence databases, this protein was identified as glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH). The DNA sequence of LA 318 GAPDH was 100% identical to the GAPDH (gapB) of L. plantarum WCFS1. The purified GAPDH adhered to HCM. Conclusions: We found the adhesin of L. plantarum LA 318 to HCM in its culture PBS wash fraction. The molecule was identified as GAPDH. Because LA 318 possesses the same adhesin as many pathogens, the lactobacilli GAPDH may compete with pathogens infecting the intestine. Significance and Impact of the Study: This is the first report showing GAPDH expressed on the cell surface of lactobacilli adheres to mucin suggesting L. plantarum LA 318 adheres to HCM using GAPDH binding activity to colonize the human intestinal mucosa.

31 July 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MNMakoto Nagashima
Makoto Nagashima
MSMasayuki Shiseki
Masayuki Shiseki
KMKoh Miura
Koh Miura
KHKoichi Hagiwara
Koichi Hagiwara
SLSteven P Linke
Steven P Linke
CHCurtis C. Harris
Curtis C. Harris
The p33ING1 protein is a regulator of cell cycle, senescence, and apoptosis. Three alternatively spliced transcripts of p33ING1 encode p47ING1a, p33ING1b, and p24ING1c. We cloned an additional ING family member, p33ING2 / ING1L . Unlike p33ING1b, p33ING2 is induced by the DNA-damaging agents etoposide and neocarzinostatin. p33ING1b and p33ING2 negatively regulate cell growth and survival in a p53-dependent manner through induction of G 1 -phase cell-cycle arrest and apoptosis. p33ING2 strongly enhances the transcriptional-transactivation activity of p53. Furthermore, p33ING2 expression increases the acetylation of p53 at Lys-382. Taken together, p33ING2 is a DNA damage-inducible gene that negatively regulates cell proliferation through activation of p53 by enhancing its acetylation.

22 January 2003 in Oncogene
Verified
Journal Article
Open access
PDF file
MNMakoto Nagashima
Makoto Nagashima
MSMasayuki Shiseki
Masayuki Shiseki
RPRémy Pedeux
Rémy Pedeux
SOShu Okamura
Shu Okamura
MKMariko Kitahama-Shiseki
Mariko Kitahama-Shiseki
CHCurtis C. Harris
Curtis C. Harris
A candidate tumor suppressor gene, p33ING1, was previously identified by using the genetic suppressor element methodology. p33ING1 cooperates with p53 and plays a significant role in p53-mediated cellular processes. Recently, we have identified p33ING2, which shows a sequence homology similar to p33ING1 and modulates p53 function. In the present study, we identified and characterized another ‘ING family’ gene. The estimated molecular weight of the encoded protein is 46.8 kDa, thus, we named it p47ING3. The p47ING3 gene is located at chromosome 7q31.3 and consists of 12 exons that encode 418 amino acids. A computational domain search revealed a C-terminal PHD-finger motif. Such motifs are common in proteins involved in chromatin remodeling. p47ING3 is highly expressed in some normal human tissues or organs, including the spleen, testis, skelet al muscle, and heart. p47ING3 expression levels varied among cancer cell lines. p47ING3 overexpression resulted in a decreased population of cells in S phase, a diminished colony-forming efficiency, and induced apoptosis in RKO cells, but not in RKO-E6 cells with inactivated p53. p47ING3 activates p53-transactivated promoters, including promoters of p21/waf1 and bax. Thus, we have isolated a novel ING family gene, p47ING3, which modulates p53-mediated transcription, cell cycle control, and apoptosis.

15 May 2003
Verified
Journal Article
Closed access
MSMasayuki Shiseki
Masayuki Shiseki
MNMakoto Nagashima
Makoto Nagashima
RPRémy Pedeux
Rémy Pedeux
MKMariko Kitahama-Shiseki
Mariko Kitahama-Shiseki
KMKoh Miura
Koh Miura
CHCurtis C. Harris
Curtis C. Harris

1 February 2003
Verified
Journal Article
Closed access
YAYuzuru Araki
Yuzuru Araki
SOShu Okamura
Shu Okamura
SHS Perwez Hussain
S Perwez Hussain
MNMakoto Nagashima
Makoto Nagashima
PHPeijun He
Peijun He
CHCurtis C. Harris
Curtis C. Harris